RNAi and CRISPR/Cas9 based in vivo models for drug discovery

被引：0
|
作者：
Premsrirut, Prem K.
Martin, Gregory
Dow, Lukas
Kim, Sang Yong
Zuber, Johannes
Lowe, Scott
Hannon, Greg
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-4188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4188
引用
收藏
页数：2
相关论文
共 50 条
  • [11] CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery
    Luo, Ji
    TRENDS IN CANCER, 2016, 2 (06): : 313 - 324
  • [12] CRISPR/Cas9 services for drug discovery and custom model development
    Ellen P. Neff
    Lab Animal, 2017, 46 : 31 - 31
  • [13] CRISPR/Cas9 services for drug discovery and custom model development
    Neff, Ellen P.
    LAB ANIMAL, 2017, 46 (02) : 31 - 31
  • [14] Modeling Disease In Vivo With CRISPR/Cas9
    Dow, Lukas E.
    TRENDS IN MOLECULAR MEDICINE, 2015, 21 (10) : 609 - 621
  • [15] CRISPR/Cas9
    杨丽
    中南医学科学杂志, 2016, 44 (05) : 585 - 585
  • [16] CRISPR/Cas9
    Mizuno, Naoaki
    Mizutani, Eiji
    Sato, Hideyuki
    Kasai, Mariko
    Nakauchi, Hiromitsu
    Yamaguchi, Tomoyuki
    BIO-PROTOCOL, 2019, 9 (13):
  • [17] Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
    David W Morgens
    Richard M Deans
    Amy Li
    Michael C Bassik
    Nature Biotechnology, 2016, 34 : 634 - 636
  • [18] Systematic comparison of CRISPR/Cas9 and RNAi screens for essential genes
    Morgens, David W.
    Deans, Richard M.
    Li, Amy
    Bassik, Michael C.
    NATURE BIOTECHNOLOGY, 2016, 34 (06) : 634 - 636
  • [19] Advances in CRISPR/Cas9 Technology for in Vivo Translation
    Cicek, Yagiz Anil
    Luther, David C.
    Kretzmann, Jessica A.
    Rotello, Vincent M.
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (03) : 304 - 311
  • [20] In vivo and in vitro disease modeling with CRISPR/Cas9
    Kato, Tomoko
    Takada, Shuji
    BRIEFINGS IN FUNCTIONAL GENOMICS, 2017, 16 (01) : 13 - 24
12345